Michael Gold
Corporate Officer/Principal bei University of South Florida
Profil
Michael Gold is currently an Assistant Professor at the University of South Florida.
He was previously the Chief Medical Officer at Cerecin, Inc. and at Allon Therapeutics, Inc. he held the position of Chief Medical Officer & VP-Clinical Development from 2011 to 2012.
Dr. Gold earned a doctorate degree from the University of Miami.
Aktive Positionen von Michael Gold
| Unternehmen | Position | Beginn |
|---|---|---|
| University of South Florida | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Gold
| Unternehmen | Position | Ende |
|---|---|---|
| ALLON THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 24.12.2012 |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Gold
| University of Miami | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
